Trial Profile
Phase I trial of POL6014 for the treatment of alpha-1 antitrypsin deficiency
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2022
Price :
$35
*
At a glance
- Drugs Lonodelestat (Primary)
- Indications Alpha 1-antitrypsin deficiency
- Focus Adverse reactions
- 05 Aug 2015 New trial record